Enhabit, Inc. $EHAB Shares Sold by Tudor Investment Corp ET AL

Tudor Investment Corp ET AL reduced its position in shares of Enhabit, Inc. (NYSE:EHAB) by 24.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 229,191 shares of the company’s stock after selling 74,355 shares during the period. Tudor Investment Corp ET AL’s holdings in Enhabit were worth $1,836,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Bailard Inc. acquired a new stake in Enhabit in the third quarter valued at $442,000. Segall Bryant & Hamill LLC acquired a new position in shares of Enhabit during the 3rd quarter worth about $1,926,000. Globeflex Capital L P acquired a new position in shares of Enhabit during the 2nd quarter worth about $1,154,000. Y Intercept Hong Kong Ltd increased its holdings in shares of Enhabit by 188.2% in the 3rd quarter. Y Intercept Hong Kong Ltd now owns 218,284 shares of the company’s stock valued at $1,748,000 after acquiring an additional 142,556 shares during the last quarter. Finally, 8 Knots Management LLC increased its holdings in shares of Enhabit by 9.5% in the 3rd quarter. 8 Knots Management LLC now owns 4,218,846 shares of the company’s stock valued at $33,793,000 after acquiring an additional 365,779 shares during the last quarter.

Enhabit Price Performance

EHAB stock opened at $13.66 on Friday. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.76. The company has a market capitalization of $692.58 million, a P/E ratio of -151.72 and a beta of 1.56. The business has a 50 day simple moving average of $12.26 and a 200-day simple moving average of $9.97. Enhabit, Inc. has a twelve month low of $6.47 and a twelve month high of $13.69.

Enhabit (NYSE:EHAB) last announced its earnings results on Wednesday, March 4th. The company reported $0.14 EPS for the quarter, meeting analysts’ consensus estimates of $0.14. Enhabit had a negative net margin of 0.43% and a positive return on equity of 4.71%. The business had revenue of $270.40 million for the quarter, compared to analysts’ expectations of $270.56 million. As a group, equities analysts anticipate that Enhabit, Inc. will post 0.22 EPS for the current year.

Insider Transactions at Enhabit

In other Enhabit news, EVP Julie Diane Jolley sold 2,793 shares of Enhabit stock in a transaction on Monday, March 9th. The shares were sold at an average price of $13.63, for a total value of $38,068.59. Following the transaction, the executive vice president directly owned 139,923 shares in the company, valued at approximately $1,907,150.49. The trade was a 1.96% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 3.40% of the company’s stock.

Analyst Ratings Changes

EHAB has been the subject of several recent analyst reports. Leerink Partners boosted their target price on Enhabit from $9.50 to $13.80 and gave the stock a “market perform” rating in a research note on Monday, February 23rd. UBS Group reiterated a “neutral” rating and issued a $13.80 price target (up from $12.00) on shares of Enhabit in a research note on Tuesday, February 24th. Weiss Ratings reissued a “sell (e+)” rating on shares of Enhabit in a report on Monday, December 29th. Citigroup restated a “buy” rating on shares of Enhabit in a research report on Tuesday, December 16th. Finally, TD Cowen restated a “hold” rating and issued a $13.80 target price (up from $12.00) on shares of Enhabit in a report on Friday, March 6th. Two equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Enhabit has a consensus rating of “Hold” and a consensus price target of $13.57.

Enhabit Company Profile

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.